<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21139" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Entamoeba histolytica Infection</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chou</surname>
            <given-names>Arthur</given-names>
          </name>
          <aff>Southern Illinois University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Austin</surname>
            <given-names>Richard L.</given-names>
          </name>
          <aff>Southern Illinois University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arthur Chou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Richard Austin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21139.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Entamoeba histolytica is a protozoan that causes intestinal amebiasis as well as extra-intestinal manifestations. Although 90 percent of E. histolytica infections are asymptomatic, nearly 50 million people become symptomatic, with about 100,000 deaths yearly. This activity reviews the evaluation and treatment of amebiasis caused by Entamoeba histolytica and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of Entamoeba histolytica medical conditions and emergencies.</p></list-item><list-item><p>Describe components of evaluation in the work-up for Entamoeba histolytica.</p></list-item><list-item><p>Summarize the management options available for Entamoeba histolytica.</p></list-item><list-item><p>Outline interprofessional team strategies for improving care coordination and communication to advance Entamoeba histolytica and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21139&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21139">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21139.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Entamoeba histolytica is a protozoan that causes intestinal amebiasis as well as extraintestinal manifestations. Although 90 percent of E. histolytica infections are asymptomatic, nearly 50 million people become symptomatic, with about 100,000 deaths yearly.<xref ref-type="bibr" rid="article-21139.r1">[1]</xref>&#x000a0;Amebic infections are more prevalent in countries with&#x000a0;lower socioeconomic conditions.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
      </sec>
      <sec id="article-21139.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Entamoeba histolytica is transmitted by&#x000a0;the ingestion of amebic cysts through fecal-oral contact, usually through contaminated food or water sources.<xref ref-type="bibr" rid="article-21139.r3">[3]</xref><xref ref-type="bibr" rid="article-21139.r4">[4]</xref></p>
      </sec>
      <sec id="article-21139.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Entamoeba histolytica continues to be an important global health issue being the third leading cause of death from parasitic infections.<xref ref-type="bibr" rid="article-21139.r5">[5]</xref>&#x000a0;Although 90 percent of <italic toggle="yes">E. histolytica</italic> infections are asymptomatic, nearly 50 million people become symptomatic, with up to 100,000 deaths yearly.<xref ref-type="bibr" rid="article-21139.r6">[6]</xref>&#x000a0;Those infected by <italic toggle="yes">Entamoeba</italic> are mostly colonized by either <italic toggle="yes">E. histolytica</italic> or <italic toggle="yes">E. dispar</italic>. <italic toggle="yes">E. histolytica</italic> is the pathogenic form and can cause amoebic colitis and extraintestinal amoebiasis.&#x000a0; <italic toggle="yes">E. dispar</italic> is considered to be nonpathogenic and causes no signs of disease.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
        <p>Infection occurs worldwide, with a higher prevalence in countries of low socioeconomic status and poor public health. Countries with a high rate of infections include India, Africa, Mexico, and Central and South America. For example, a three-year study conducted in Bangladesh showed that 2.2% of dysentery cases were caused by&#x000a0;<italic toggle="yes">E. histolytica</italic> in preschool children.<xref ref-type="bibr" rid="article-21139.r7">[7]</xref>&#x000a0;In rural areas of Mexico, the seroprevalence of E. histolytica has been reported as high as 42%.<xref ref-type="bibr" rid="article-21139.r8">[8]</xref>&#x000a0; Risk factors for infection are mostly related to fecal-oral transmission and have been due to poor hand hygiene, defecation into water sources such as rivers, and being in close proximity with animals. In developed countries such as the United States, amebiasis infections are rare, accounting for at least 5 deaths per year, and are commonly seen in individuals that have had exposure to endemic areas such as immigrants or recent travelers.<xref ref-type="bibr" rid="article-21139.r8">[8]</xref></p>
        <p>Amoebic colitis generally affects males and females of all ages equally. There are reports of increased risk of infection from gay or bisexual males due to the risk of fecal-oral contamination through oral and anal sex.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref>&#x000a0;Factors that are associated with increased risk for complicated infection and mortality are associated with the following: pregnancy, corticosteroid treatment, malignancy, malnutrition, and alcoholism. Amoebic liver abscess infections are at least 3 times more likely to affect middle-aged men between the ages of 18 and 50.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
      </sec>
      <sec id="article-21139.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>There are two forms E. histolytica can take: the cyst form, which can survive in the environment for a prolonged period, and the trophozoite stage, which is the active and invasive form. After&#x000a0;the ingestion of the cyst form, trophozoites can be formed, which can invade and penetrate intestinal mucosa destroying epithelial cells and inflammatory cells.</p>
        <p>The pathogenesis of infection by trophozoites is due to the adherence of colonic epithelial cells through a specific galactose-N-acetylgalactosamine lectin.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref>&#x000a0;Through the direct adherence of trophozoites to the colonic epithelial cells, the colonic epithelial cells die off through cytolysis and apoptosis, which results in the release of interleukin-1&#x003b1; and precursor interleukin-1&#x003b2;.&#x000a0; IL-1&#x003b2; activates NF-&#x003ba;B in distal cells to produce cytokines and other inflammatory mediators such as COX-2, interleukin-1, and interleukin-8. Amoebic cysteine proteinases can also convert precursor IL-1&#x003b2; to active IL-1&#x003b2;, which can further facilitate the process. These cytokines and inflammatory mediators subsequently attract neutrophils and macrophages. Neutrophils can be damaged by direct contact with trophozoites which can cause more damage to colonic epithelial cells resulting in the release of more mediators. Macrophages release other mediators as well, such as TNF&#x003b1;, which further contributes to inflammation.</p>
        <p>The pathological range includes mucosal inflammation, thickening, ulcers, and necrosis, leading to perforation. Amoebic cysteine proteinases can also contribute to trophozoites' ability to suppress a host&#x02019;s immune response by being able to cleave and inactivate anaphylatoxins C3a, C5a, IgA, and IgG.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref>&#x000a0;Trophozoites can reach other areas of the body, most commonly the liver, which can cause tissue necrosis and abscess formation.<xref ref-type="bibr" rid="article-21139.r7">[7]</xref></p>
      </sec>
      <sec id="article-21139.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The majority of <italic toggle="yes">E. histolytica</italic> infections are asymptomatic; however, up to 10% of asymptomatic individuals infected can develop the disease over time.<xref ref-type="bibr" rid="article-21139.r8">[8]</xref>&#x000a0;<italic toggle="yes">E. histolytica</italic> most commonly causes intestinal amoebiasis but can also affect the liver, respiratory tract, heart, and brain.&#x000a0;</p>
        <p><bold>Gastrointestinal:</bold> Symptoms typically have a gradual onset, usually over one to three weeks.&#x000a0; Common symptoms include diarrhea, bloody stools, weight loss, and abdominal pain.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
        <p><bold>Liver:</bold> Amoebic liver abscess formation is the most common extraintestinal complication. It can be seen in months to years after an individual has had exposure to an endemic area. Symptoms include fever and right upper quadrant pain. Exam findings may include hepatomegaly with hepatic tenderness. Less than 10 percent of patients have jaundice. Common laboratory findings include leukocytosis without eosinophilia, elevated alkaline phosphatase, transaminitis, and elevated erythrocyte sedimentation rate.</p>
        <p><bold>Respiratory tract:</bold> Pleuropulmonary involvement is a rare complication that causes atelectasis and transudative pleural effusions.&#x000a0; In rare cases, an amoebic liver abscess can rupture into the pleural space causing empyema or hepato-bronchial fistula causing fevers, coughing, and respiratory distress.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref>&#x000a0;</p>
        <p><bold>Cardiac infection:</bold> Cardiac infection is an even less common complication than pleuropulmonary disease and occurs with a liver abscess ruptures into the pericardium and presents with symptoms of pericarditis or cardiac tamponade.</p>
        <p><bold>Brain infection:</bold> Amoebic brain abscesses are very rare with sudden onset symptoms such as headache, vomiting, and mental status changes with rapid progression to death.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
      </sec>
      <sec id="article-21139.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Historically amoebic infections were diagnosed by microscopy with the identification of trophozoites; however, this method was unable to distinguish between <italic toggle="yes">E. histolytica</italic> and <italic toggle="yes">E. dispar</italic> infections.&#x000a0; Now, there&#x000a0;are many tools used for diagnosis with stool polymerase chain reaction (PCR) having the highest sensitivity in distinguishing <italic toggle="yes">E. histolytica</italic> from <italic toggle="yes">E. dispar</italic>.&#x000a0; Other diagnostic modalities available include&#x000a0;stool microscopy, stool antigen detection, serology, stool molecular studies, and colonoscopy with a histologic examination.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
        <p>Stool microscopy: This diagnostic method is advantageous, being widely available with minimal equipment needed and can be used to screen for other parasites.&#x000a0; Disadvantages include poor sensitivity, reported&#x000a0;at&#x000a0;&#x0003c;60%, with the inability to differentiate from other Entamoeba species and relies on the experience or skills of the observer.<xref ref-type="bibr" rid="article-21139.r8">[8]</xref><xref ref-type="bibr" rid="article-21139.r9">[9]</xref>&#x000a0;&#x000a0;</p>
        <p>Stool antigen detection: This method is simple with a quick turnaround time and has the advantage of being able to differentiate between E. histolytica and <italic toggle="yes">E. dispar</italic>.&#x000a0; There are a wide number of commercially available antigen detection kits using enzyme-linked immunosorbent assay (ELISA), radioimmunoassay, or immunofluorescence that have varying sensitivities of up to 88%.<xref ref-type="bibr" rid="article-21139.r10">[10]</xref><xref ref-type="bibr" rid="article-21139.r8">[8]</xref><xref ref-type="bibr" rid="article-21139.r9">[9]</xref></p>
        <p>Serology: Has high sensitivity and specificity with quick turnaround time but is not helpful in distinguishing between an acute or previous infection.&#x000a0; &#x000a0;Antibodies are not detectable in an active infection until at least a week into the infection and&#x000a0;will remain detectable in individuals for years.</p>
        <p>Stool molecular studies: Considered to be the gold standard with high sensitivity of 92%&#x000a0;to 100% and specificity of 89% to 100%.&#x000a0; Testing is becoming more widely available&#x000a0;but is considered to be more expensive, requiring appropriate equipment and kits and requiring a skilled technician.</p>
        <p>Colonoscopy with histologic examination: Not used for routine diagnosis but can be used to look for other causes of symptoms.&#x000a0; Used to look for characteristic findings of amebic ulcers or erosions with the identification of trophozoites or cysts with biopsy specimens.<xref ref-type="bibr" rid="article-21139.r8">[8]</xref></p>
      </sec>
      <sec id="article-21139.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Due to the risk of spread and the risk of developing extraintestinal manifestations, all <italic toggle="yes">E. histolytica</italic> infections need to be treated.&#x000a0;</p>
        <p>Metronidazole is the first-line treatment for intestinal amebiasis and amebic liver abscess followed by a luminal agent. Typical dosing for metronidazole is 500 to 750 mg orally 3 times a day for 7 to 10 days in adults.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref>&#x000a0;Metronidazole can be safely used in children at a dosing of 35 mg/kg to 50 mg/kg per day divided into three doses.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref>&#x000a0;Luminal agents include the following: paromomycin, diiodohydroxyquin, or diloxanide furoate. Dosing for paromomycin is 25 mg/kg to 30 mg/kg per day divided into three doses for 7 days, diiodohydroxyquin is 650 mg orally for 20 days, diloxanide furoate is 500 mg orally three times a day for 10 days.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
        <p>Alternatives to metronidazole include tinidazole, ornidazole, and nitazoaxanide.&#x000a0;</p>
        <p>In patients with fulminant amoebic colitis or signs of peritonitis, broad-spectrum antibiotics should be started. Surgical intervention may be required with bowel perforation or toxic megacolon.&#x000a0; &#x000a0;</p>
        <p>In uncomplicated cases of amebic liver abscess, it has been shown that there is no benefit to drainage in addition to medical therapy.<xref ref-type="bibr" rid="article-21139.r11">[11]</xref>&#x000a0;In situations where there is a lack of clinical response to antibiotic therapy, aspiration or catheter drainage may be necessary.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
        <p>Pleuropulmonary infections should be treated&#x000a0;by aspiration of amebic pleural effusion followed by antimicrobial therapy such as metronidazole with a luminal agent.<xref ref-type="bibr" rid="article-21139.r12">[12]</xref></p>
      </sec>
      <sec id="article-21139.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for <italic toggle="yes">E. histolytica</italic> intestinal amebiasis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial pathogens: <italic toggle="yes">Shigella</italic>, <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Campylobacter</italic>, and <italic toggle="yes">Clostridioides difficile</italic></p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Ischemic bowel disease</p>
          </list-item>
        </list>
        <p>The differential diagnosis for <italic toggle="yes">E. histolytica</italic> extraintestinal amebiasis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pyogenic liver abscess</p>
          </list-item>
          <list-item>
            <p>Echinococcal disease</p>
          </list-item>
          <list-item>
            <p>Malignancy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21139.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Uncomplicated infections and early treatment have a mortality rate of less than&#x000a0;1 percent. Risk factors for complicated infections and increased mortality include the following:<xref ref-type="bibr" rid="article-21139.r13">[13]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Young age&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pregnancy&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Corticosteroid treatment</p>
          </list-item>
          <list-item>
            <p>Malignancy&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Malnutrition&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Alcoholism&#x000a0;</p>
          </list-item>
        </list>
        <p>Fulminant amoebic colitis is associated with 40% mortality.<xref ref-type="bibr" rid="article-21139.r13">[13]</xref>&#x000a0;Amebic liver abscess with prompt medical treatment has been highly effective, with mortality rates between 1 and&#x000a0;3 percent.<xref ref-type="bibr" rid="article-21139.r2">[2]</xref>&#x000a0; Pleuropulmonary amebiasis is associated with mortality up to 16%, while cardiac involvement has a mortality of up to 30%.<xref ref-type="bibr" rid="article-21139.r14">[14]</xref></p>
      </sec>
      <sec id="article-21139.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of <italic toggle="yes">E. histolytica</italic> infection can involve any of the following:<xref ref-type="bibr" rid="article-21139.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Asymptomatic infection</p>
          </list-item>
          <list-item>
            <p>Symptomatic noninvasive infection</p>
          </list-item>
          <list-item>
            <p>Acute proctocolitis</p>
          </list-item>
          <list-item>
            <p>Fulminant amoebic colitis with perforation</p>
          </list-item>
          <list-item>
            <p>Toxic megacolon</p>
          </list-item>
          <list-item>
            <p>Chronic non-dysenteric colitis</p>
          </list-item>
        </list>
        <p>Extraintestinal conditions resulting from E. histolytica infection include the following:<xref ref-type="bibr" rid="article-21139.r2">[2]</xref><xref ref-type="bibr" rid="article-21139.r15">[15]</xref><xref ref-type="bibr" rid="article-21139.r16">[16]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Liver abscess</p>
          </list-item>
          <list-item>
            <p>Pleuropulmonary disease</p>
          </list-item>
          <list-item>
            <p>Brain abscess</p>
          </list-item>
          <list-item>
            <p>Peritonitis</p>
          </list-item>
          <list-item>
            <p>Pericarditis</p>
          </list-item>
          <list-item>
            <p>Genitourinary disease</p>
          </list-item>
          <list-item>
            <p>Perianal cutaneous amebiasis</p>
          </list-item>
          <list-item>
            <p>Hepatic vein thrombosis</p>
          </list-item>
          <list-item>
            <p>Inferior vena cava thrombosis</p>
          </list-item>
          <list-item>
            <p>Ameboma&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Appendicitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21139.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>You can reduce your chances of getting bacterial and parasitic infections such as <italic toggle="yes">E. histolytica</italic> by watching what you eat and proper hand hygiene. If&#x000a0;a person&#x000a0;is traveling outside of the United States, they need&#x000a0;to be sure to do the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Avoid drinking tap water.&#x000a0; Drink bottled beverages and brush your teeth with bottled water.&#x000a0; &#x000a0;Avoid ice in drinks as they are commonly made from tap water.</p>
          </list-item>
          <list-item>
            <p>Avoid eating raw fruits and vegetables cleaned with tap water.</p>
          </list-item>
          <list-item>
            <p>Eat well-cooked food when traveling, avoiding undercooked fish or meats.</p>
          </list-item>
          <list-item>
            <p>Avoid eating street vendors in carts or stands.</p>
          </list-item>
          <list-item>
            <p>Frequently wash hands after using the restroom, touching animals, before eating, or handling trash.</p>
          </list-item>
        </list>
        <p>A patient&#x000a0;should see a&#x000a0;clinician if you have any of the following symptoms with any recent travel out of the country if:</p>
        <list list-type="bullet">
          <list-item>
            <p>They&#x000a0;have a fever of 102&#x000a0;degrees F (40&#x000a0;degrees C) or higher.</p>
          </list-item>
          <list-item>
            <p>They&#x000a0;have severe abdominal pain.</p>
          </list-item>
          <list-item>
            <p>They&#x000a0;have bloody diarrhea.</p>
          </list-item>
          <list-item>
            <p>They&#x000a0;have been sick for longer than two weeks.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21139.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Amebiasis is a relatively common parasitic infection worldwide. Occurring much more commonly in endemic areas of poor socioeconomic status. An important component of prevention is patient education through interprofessional communication. Physicians, nurse practitioners, nurses, and pharmacists should educate patients if they are traveling to endemic areas in the world on common steps they can take to reduce their chance of contracting amebiasis. Specifically, they should educate patients to avoid consumption of tap water and avoid raw fruits and vegetables that have been cleaned with tap water. Patients should be encouraged to contact their healthcare provider if they have symptoms of diarrhea and blood stools after traveling to an endemic area. Open communication, especially in&#x000a0;obtaining a good history, will be critical in early diagnosis and treatment. Following treatment, the prognosis has been proven to be favorable.<xref ref-type="bibr" rid="article-21139.r17">[17]</xref></p>
      </sec>
      <sec id="article-21139.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21139&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21139">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/entamoeba-histolytica-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21139">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21139/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21139">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21139.s15">
        <title>References</title>
        <ref id="article-21139.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bercu</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Behm</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Amebic colitis: new insights into pathogenesis and treatment.</article-title>
            <source>Curr Gastroenterol Rep</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>429</fpage>
            <page-range>429-33</page-range>
            <pub-id pub-id-type="pmid">17991346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanley</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Amoebiasis.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>Mar</month>
            <day>22</day>
            <volume>361</volume>
            <issue>9362</issue>
            <fpage>1025</fpage>
            <page-range>1025-34</page-range>
            <pub-id pub-id-type="pmid">12660071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salit</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Khairnar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gough</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pillai</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain.</article-title>
            <source>Clin Infect Dis</source>
            <year>2009</year>
            <month>Aug</month>
            <day>01</day>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-53</page-range>
            <pub-id pub-id-type="pmid">19580413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Billet</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Salmon Rousseau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Piroth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>An underestimated sexually transmitted infection: amoebiasis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2019</year>
            <month>May</month>
            <day>10</day>
            <volume>12</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">31079045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Padalia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moonah</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Tissue Destruction Caused by <italic>Entamoeba histolytica</italic> Parasite<italic>:</italic> Cell Death, Inflammation, Invasion, and the Gut Microbiome.</article-title>
            <source>Curr Clin Microbiol Rep</source>
            <year>2019</year>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-57</page-range>
            <pub-id pub-id-type="pmid">31008019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stauffer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ravdin</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Entamoeba histolytica: an update.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>479</fpage>
            <page-range>479-85</page-range>
            <pub-id pub-id-type="pmid">14502002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haque</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huston</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Houpt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Amebiasis.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Apr</month>
            <day>17</day>
            <volume>348</volume>
            <issue>16</issue>
            <fpage>1565</fpage>
            <page-range>1565-73</page-range>
            <pub-id pub-id-type="pmid">12700377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shirley</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Farr</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moonah</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>7</issue>
            <fpage>ofy161</fpage>
            <pub-id pub-id-type="pmid">30046644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saidin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Othman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Noordin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Update on laboratory diagnosis of amoebiasis.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-38</page-range>
            <pub-id pub-id-type="pmid">30255429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spadafora</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Siddique</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Gilchrist</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Arju</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hoffstrom</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Haque</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cangelosi</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Species-Specific Immunodetection of an Entamoeba histolytica Cyst Wall Protein.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2016</year>
            <month>May</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>e0004697</fpage>
            <pub-id pub-id-type="pmid">27152855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chavez-Tapia</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Hernandez-Calleros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tellez-Avila</surname>
                <given-names>FI</given-names>
              </name>
              <name>
                <surname>Torre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uribe</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2009</year>
            <month>Jan</month>
            <day>21</day>
            <issue>1</issue>
            <fpage>CD004886</fpage>
            <pub-id pub-id-type="pmid">19160244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fung</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Doan</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Tinidazole: a nitroimidazole antiprotozoal agent.</article-title>
            <source>Clin Ther</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>12</issue>
            <fpage>1859</fpage>
            <page-range>1859-84</page-range>
            <pub-id pub-id-type="pmid">16507373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kantor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abrantes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Estevez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schiller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Torrent</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gascon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ochner</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development.</article-title>
            <source>Can J Gastroenterol Hepatol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>4601420</fpage>
            <pub-id pub-id-type="pmid">30631758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zakaria</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Share</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Al Asad</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Primary Pulmonary Amebiasis Complicated with Multicystic Empyema.</article-title>
            <source>Case Rep Pulmonol</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>8709347</fpage>
            <pub-id pub-id-type="pmid">27478673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Burute</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Haider</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Serrano</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>O'Shea</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Siegal</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Occult Amebic Liver Abscess as Cause of Extensive Inferior Vena Cava and Hepatic Vein Thrombosis.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>97</volume>
            <issue>4</issue>
            <fpage>1214</fpage>
            <page-range>1214-1217</page-range>
            <pub-id pub-id-type="pmid">28722597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ito</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seiichiro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Teruya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaminishi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Amebiasis presenting as acute appendicitis: Report of a case and review of Japanese literature.</article-title>
            <source>Int J Surg Case Rep</source>
            <year>2014</year>
            <volume>5</volume>
            <issue>12</issue>
            <fpage>1054</fpage>
            <page-range>1054-7</page-range>
            <pub-id pub-id-type="pmid">25460473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21139.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Zulfiqar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Horrall</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Amebiasis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">30137820</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
